We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Single Chest X-Ray Predicts Mortality Risk

By HospiMedica International staff writers
Posted on 08 Aug 2019
A new study suggests that a convolutional neural network (CNN) can stratify all-cause mortality risk based on a single chest radiograph.

Developed at Massachusetts General Hospital (MGH; Boston, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions, the CNN algorithm, named CXR-risk, uses data from radiologists' diagnostic findings (such as presence of a lung nodule) on a chest x-ray, and combines it with other risk factors, including age, sex and comorbidities in order to predict long-term mortality, including non-cancer death. More...
A deep learning CXR-risk score (very low, low, moderate, high, and very high) is generated based on CNN analysis of a submitted radiograph.

To develop the CNN, the researchers used 41,856 x-rays from the screening radiography arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, a community cohort of asymptomatic nonsmokers and smokers enrolled at 10 U.S. sites from November 8, 1993, through July 2, 2001. The results of the CNN were tested in a further 10,464 cases from the screening radiography arm of the National Lung Screening Trial (NLST), a community cohort of heavy smokers enrolled at 21 U.S. sites from August 2002 through April 2004.

The results revealed a graded association between CXR-risk score and mortality. The very high-risk group had an all-cause mortality of 53% (PLCO) and 33.9% (NLST), compared with the very low-risk group. The association was robust to adjustment for radiologists’ findings and risk factors. Comparable results were seen for lung cancer death, non-cancer cardiovascular death, and respiratory death. The study was published on July 19, 2019, in JAMA Network Open.

“We get chest x-rays to make a diagnosis like pneumonia, but our study shows that there is also free prognostic information about health and longevity on the images. Based on the chest x-ray image alone, AI identified people at up to a 53% risk of death over 12 years,” said lead author Michael Lu, MD, MPH, of MGH and HMS. “Scores calculated using AI may incentivize high-risk individuals to lower their chance of dying with prevention, regular screening, and lifestyle modification.”

Deep learning is part of a broader family of AI machine learning methods based on learning data representations, as opposed to task specific algorithms. It involves CNN algorithms that use a cascade of many layers of nonlinear processing units for feature extraction, conversion and transformation, with each successive layer using the output from the previous layer as input to form a hierarchical representation.

Related Links:
Massachusetts General Hospital
Harvard Medical School


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gas Analyzer
GE SAM
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.